Literature DB >> 309336

The effect of deoxyuridine, vitamin B12, folate and alcohol on the uptake of thymidine and on the deoxynucleoside triphosphate concentrations in normal and megaloblastic cells.

K Ganeshaguru, A V Hoffbrand.   

Abstract

Deoxyuridine suppression of labelled thymidine uptake tests were performed in the bone marrows of 58 patients with megaloblastic anaemia (haemoglobin less than 10.0 g/dl) and invariably gave values (range 10.3-58.8%) above the range in 16 control marrows (range 1.0-9.0%). Folinic acid corrected the test equally well in either folate or vitamin B12 deficiency, even at concentrations as low as 60 ng/ml. Folic acid also corrected the test equally well in either deficiency but was only effective at concentrations down to 5 microgram/ml. Vitamin B12 (100 microgram/ml) only corrected the test in vitamin B12 deficiency and 5-methyltetrahydrofolate only corrected the test in folate deficiency at the concentrations tested between 60 and 1.2 microgram/ml. Among 16 patients with subnormal serum levels of both vitamin B12 and folate, vitamin B12 partially corrected the test in eight, including all five with pernicious anaemia, but had no effect in the other eight. Despite the clear-cut results of the dU suppression test, measurement of the deoxythymidine triphosphate (dTTP) concentration in normal and megaloblastic phytohaemagglutinin stimulated lymphocyte cultures or short-term bone marrow cultures gave no clear-cut differences between normal and megaloblastic cells after addition of deoxyuridine nor did the addition of vitamin B12, folic acid or folinic acid either alone or with deoxyuridine produce consistent changes in the dTTP concentration in lymphocytes or bone marrow cells in megaloblastic anaemia. Alcohol caused a rise in deoxyadenosine triphosphate concentration in normal PHA-stimulated lymphocytes which was concentration dependent but caused no consistent change in any of the other three deoxynucleoside triphosphate (dNTP) concentrations. Diphenylhydantoin (10(-3)M, 10(-4)M) had no consistent effect on any of the four dNTP concentrations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309336     DOI: 10.1111/j.1365-2141.1978.tb03636.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  The action of vitamin B12.

Authors:  T E Parry
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

Review 2.  Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics.

Authors:  Klaus Pietrzik; Lynn Bailey; Barry Shane
Journal:  Clin Pharmacokinet       Date:  2010-08       Impact factor: 6.447

3.  Biochemical mechanisms in the Killmann experiment: critique of the deoxyuridine suppression test.

Authors:  T T Pelliniemi; W S Beck
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

4.  Reduced rate of DNA replication fork movement in megaloblastic anemia.

Authors:  R G Wickremasinghe; A V Hoffbrand
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Metabolism of thymine nucleotides synthesized via the 'de novo' mechanism in normal, megaloblastic and methotrexate-treated human cells and in a lymphoblastoid cell line.

Authors:  M R Taheri; R G Wickremasinghe; A V Hoffbrand
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

6.  Alternative metabolic fates of thymine nucleotides in human cells.

Authors:  M R Taheri; R G Wickremasinghe; A V Hoffbrand
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

7.  Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum.

Authors:  Mary Rose Sweeney; Joseph McPartlin; John Scott
Journal:  BMC Public Health       Date:  2007-03-22       Impact factor: 3.295

8.  Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification?

Authors:  Mary R Sweeney; Anthony Staines; Leslie Daly; Aisling Traynor; Sean Daly; Steven W Bailey; Patricia B Alverson; June E Ayling; John M Scott
Journal:  BMC Public Health       Date:  2009-08-18       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.